900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Carbidopa + levodopa 25mg/100mg m/r tablet	Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 50mg/200mg m/r tablet	Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet	Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet
Carbidopa 25mg	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet	Carbidopa anhydrous (as carbidopa) 31.25 mg and entacapone 200 mg and levodopa 125 mg oral tablet
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop	Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup	Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup	Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops	Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet	Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet	Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent	Carbohydrate
Carbol fuchsin stain	Carbol-fuchsin (substance)
Carbon-carbon lyase	Carbon-carbon lyase
Carbon-halide lyase	Carbon-halide lyase
Carbon-nitrogen lyase	Carbon-nitrogen lyase
Carbon-oxygen lyase	Carbon-oxygen lyase
Carbon-sulfur lyase	Carbon-sulfur lyase
Carboplatin 600mg/60mL infusion	Antineoplastic agent (substance)
Carboxy-lyase	Decarboxylase
Carboxylic ester hydrolase	Carboxylesterase
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe	Carmellose and hydroxyapatite only product in parenteral dose form
Carboxymethylcellulose sodium 16.58% oral paste	Carmellose 166 mg/g oromucosal paste
Carbuncle of other specified site	Carbuncle (disorder)
adénome carcinoïde bronchique	Carcinoid tumour of bronchus
Carcinoid bronchial adenoma	Well-differentiated neuroendocrine tumor (morphologic abnormality)
néoplasme carcinoïde	Well-differentiated neuroendocrine tumour
Carcinoid tumor - morphology	Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoid tumor no International Classification of Diseases for Oncology subtype	Well-differentiated neuroendocrine tumor (morphologic abnormality)
tumeur carcinoïde de l'ampoule de Vater	Well-differentiated neuroendocrine tumor of ampulla of Vater (disorder)
Carcinoid tumor of appendix	Well-differentiated neuroendocrine tumor of appendix (disorder)
tumeur carcinoide du tractus gastrointestinal	Well-differentiated neuroendocrine tumor of gastrointestinal tract
tumeur carcinoïde de l'iléon	Well-differentiated neuroendocrine tumor of ileum
tumeur carcinoïde de l'intestin	Well-differentiated neuroendocrine tumour of intestine
tumeur carcinoïde du colon	Well-differentiated neuroendocrine tumor of large intestine
tumeur carcinoide du pancréas	Neuroendocrine tumor of pancreas (disorder)
néoplasme carcinoïde du rectum	Well-differentiated neuroendocrine tumour of rectum
tumeur carcinoïde de l'intestin grêle	Well-differentiated neuroendocrine tumor of small intestine (disorder)
néoplasme carcinoïde gastrique	Well-differentiated neuroendocrine tumour of stomach
Carcinoid tumor of uncertain malignant potential	Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoma in situ - category	Carcinoma in situ (morphologic abnormality)
Carcinoma in situ NOS	Carcinoma in situ (disorder)
Carcinoma in situ NOS	Carcinoma in situ (disorder)
Carcinoma in situ neoplastic process	Carcinoma in situ (morphologic abnormality)
carcinome in situ de l'aréole du sein chez la femme	Carcinoma in situ of areola (disorder)
carcinome in situ aréolaire du sein chez l'homme	Carcinoma in situ of areola (disorder)
carcinome in situ du processus axillaire du sein chez la femme	Carcinoma in situ of axillary tail of breast
carcinome in situ de la partie centrale du sein	Carcinoma in situ of central portion of breast (disorder)
carcinome in situ de tissu mammaire ectopique chez la femme	Carcinoma in situ of ectopic site of breast (disorder)
carcinome in situ du tissu mammaire ectopique chez l'homme	Carcinoma in situ of ectopic site of breast (disorder)
carcinome in situ d'un sein de la femme	Carcinoma in situ of breast
carcinome in situ du quadrant inféro-interne du sein	Carcinoma in situ of lower inner quadrant of breast
carcinome in situ du quadrant inféro-externe du sein	Carcinoma in situ of lower outer quadrant of breast (disorder)
carcinome in situ du sein de l'homme	Carcinoma in situ of breast
carcinome in situ du mamelon du sein féminin	Carcinoma in situ of nipple (disorder)
carcinome in situ du mamelon du sein chez l'homme	Carcinoma in situ of nipple (disorder)
Carcinoma in situ of other and unspecified female genital organs	Carcinoma in situ of female genital organ
Carcinoma in situ of other and unspecified female genital organs	Carcinoma in situ of female genital organ
Carcinoma in situ of other and unspecified male genital organs	Carcinoma in situ of male genital organ
Carcinoma in situ of other and unspecified male genital organs	Carcinoma in situ of male genital organ
Carcinoma in situ of skin of other and unspecified parts of face	Carcinoma in situ of skin of face
Carcinoma in situ of skin of other and unspecified parts of face	Carcinoma in situ of skin of face
Carcinoma in situ of skin of other and unspecified parts of face NOS	Carcinoma in situ of skin of face
carcinome in situ du quadrant supéro-interne du sein	Carcinoma in situ of upper inner quadrant of breast
carcinome in situ du quadrant supéro-externe du sein	Carcinoma in situ of upper outer quadrant of breast
Carcinoma in situ tumour	Carcinoma in situ (disorder)
Carcinoma in situ, no International Classification of Diseases for Oncology subtype	Carcinoma in situ (morphologic abnormality)
Carcinoma liver/biliary system NOS	Carcinoma liver and/or biliary system (disorder)
Carcinoma of cervix stage 0	Carcinoma in situ of uterine cervix
Carcinoma of genital organs NOS	Carcinoma of genital organ (disorder)
Carcinoma of genital organs NOS	Carcinoma of genital organ (disorder)
carcinome du sein chez l'homme	Carcinoma of breast
Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding	American Joint Committee on Cancer allowable value
Carcinoma resembling breast carcinoma	Carcinoma (morphologic abnormality)
Carcinoma, no subtype	Carcinoma (morphologic abnormality)
Cardiac access incision	Making a cut in something
arrêt cardiaque comme complication des soins	Cardiac arrest (disorder)
Cardiac arrest, unspecified	Cardiac arrest (disorder)
Cardiac arrest, unspecified	Cardiac arrest (disorder)
Cardiac disease monitoring NOS	Cardiac disease monitoring
Cardiac disease monitoring NOS	Cardiac disease monitoring
Cardiac dysrhythmia NOS	A disorder in which there is abnormal electrical activity in the heart.
Cardiac dysrhythmia NOS	A disorder in which there is abnormal electrical activity in the heart.
Cardiac end diastolic volume, function (observable entity)	Cardiac end-diastolic volume (observable entity)
Cardiac enzymes NOS	Cardiac enzymes/isoenzymes measurement
Cardiac enzymes NOS	Cardiac enzymes/isoenzymes measurement
Cardiac function tests NOS	Cardiac function testing
Cardiac function tests NOS	Cardiac function testing
Cardiac glycoside adverse reaction	Adverse reaction to Digitalis glycoside
défaillance cardiaque comme complication des soins	Heart failure
Cardiac pacing NOS	Cardiac pacing
Cardiac pacing NOS	Cardiac pacing
Cardiac status not worse than preoperative baseline	Cardiac status is consistent with or improved from preoperative baseline (finding)
Cardio-oesophageal X-ray	Plain X-ray of cardioesophageal junction with contrast
Cardioesophageal X-ray	Plain X-ray of cardioesophageal junction with contrast
service de cardiologie	Cardiology service (qualifier value)
Cardiomyopathy NOS	Cardiomyopathy
Cardiomyopathy NOS	Cardiomyopathy

Start Previous Page 30 of 235 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)